跳至主要内容
临床试验/TCTR20220217002
TCTR20220217002已完成4 期

The Comparison of Autologous Cultured Fibroblast and Hyaluronic Acid Filler in the Treatment of Nasolabial folds: A Pilot Study

Research department, Faculty of Medicine Siriraj Hospital0 个研究点目标入组 55 人开始时间: 2022年2月17日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
55

研究概览

简要总结

Autologous fibroblast injection is a safe and effective treatment for NLFs. Unlike conventional fillers, the autologous cultured fibroblast cells are injected more superficially and may require a longer period to show improvement. It also offers the promise of sustained growth of living cells, which may lead to greater persistence than other fillers.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • patients who expressed dissatisfaction with their nasolabial folds based on a score of -1 or -2 on the Subject Wrinkle Assessment Scale

排除标准

  • (1) were pregnant or lactating; (2) had a history of connective tissue disorder, skin cancers, or related diseases; (3) had previous autologous fibroblast treatment; (4) had previous treatment with fillers, lasers or energy-based devices within the last 12 months; (5) had previous treatment using transdermal drug delivery, chemical peeling or topical retinoid within the last month; or (6) had allergy to collagen, meat and dairy products, gentamycin, amphotericin B, or related products.

研究者

发起方
Research department, Faculty of Medicine Siriraj Hospital

相似试验